Rallybio (RLYB) Interest Coverage Ratio (2020 - 2026)
Rallybio (RLYB) posted Interest Coverage Ratio of 11.66 for Q1 2026, up 83.82% sequentially from 72.04 in Q4 2025, and up 99.04% YoY from 5.86 in Q1 2025.
Rallybio (RLYB) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Rallybio has reported Interest Coverage Ratio for 7 years, with the latest figure at 11.66 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 99.04% year-over-year to 11.66 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 42.89 (up 99.32% YoY) and the FY2025 annual result came in at 165.32, down 26680.88% from the prior year.
- Interest Coverage Ratio grew to 11.66 in Q1 2026 per RLYB's latest filing, from 72.04 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.12 in Q4 2024 and troughed at 12066.0 in Q3 2024.
- A 5-year average of 913.9 and a median of 85.46 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio jumped 99.68% in 2023, then slumped 60723.61% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 85.46 in 2022, then jumped by 99.68% to 0.27 in 2023, then surged by 56.08% to 0.12 in 2024, then plunged by 60723.61% to 72.04 in 2025, then surged by 83.82% to 11.66 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 11.66, 72.04, and 150.54 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Rallybio | 94.61 Mn | 94.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.41 |
| Mar 31, 2026 | -11.66 |
| Dec 31, 2025 | -72.04 |
| Sep 30, 2025 | -150.54 |
| Jun 30, 2025 | -1,005.70 |
| Mar 31, 2025 | -1,208.75 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -12,066.00 |
| Jun 30, 2024 | -227.13 |
| Mar 31, 2024 | -250.47 |
| Dec 31, 2023 | -0.27 |
| Sep 30, 2023 | -87.22 |
| Jun 30, 2023 | -71.73 |
| Mar 31, 2023 | -206.45 |
| Dec 31, 2022 | -85.46 |
| Sep 30, 2022 | -4.33 |
| Jun 30, 2022 | -26.21 |
| Mar 31, 2022 | -62.25 |
| Dec 31, 2021 | 208.69 |
| Sep 30, 2021 | -332.70 |